News | December 05, 2025
Granules’ packaging facility in US completes FDA inspection with zero observations
Granules Consumer Health serves as Granules’ front-end division for OTC products in the US
Granules Consumer Health serves as Granules’ front-end division for OTC products in the US
Implementing PFAS testing in the early development stages allows medical device manufacturers to prepare for potential regulatory updates
This is the first time in history that an NDA for a New Chemical Entity (NCE) from an Indian pharmaceutical company has been filed and accepted by the USFDA
The audit was completed with zero critical and zero major observations
Most recently, Yuvraj was the Director of Operations, Business Development & Process Excellence at Zeon Lifesciences Ltd
RK Pharma will manufacture and supply the finished product, while Zydus will be responsible for the NDA submission and commercialization of the product in the US
Owlet’s push comes as parents demand smarter, more dependable nursery tech
A key highlight will be Brenntag’s qualified amino acids portfolio
These certifications reflect the company's continuous commitment to maintaining international standards of environmental sustainability as well as occupational health and safety
Subscribe To Our Newsletter & Stay Updated
